Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Director departure
Appointed director
Inv. presentation

Sorrento Therapeutics, Inc. (SRNE) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/03/2019 8-K/A Other Events, Financial Statements and Exhibits
Docs: "Complaint filed on behalf of Immunotherapy NANTibody LLC on April 3, 2019 in the Los Angeles Superior Court"
01/20/2017 8-K/A Form 8-K/A - Current report [Amend]
02/05/2016 8-K/A Form 8-K/A - Current report [Amend]
03/03/2014 8-K/A Financial Statements and Exhibits
Docs: "Consent of Mayer Hoffman McCann, P.C",
"Audited consolidated financial statements of Concortis Biosystems, Corp. and Subsidiary as of and for the year ending December 31, 2012",
"Unaudited consolidated financial statements of Concortis Biosystems, Corp. and Subsidiary for the nine months ending September 30, 2013",
"Sorrento Therapeutics, Inc. Unaudited Pro Forma Condensed Consolidated Financial Information"
10/07/2013 8-K/A Form 8-K/A - Current report [Amend]
09/30/2013 8-K/A Form 8-K/A - Current report [Amend]
09/22/2009 8-K/A Form 8-K/A - Current report [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy